Importance of vitamin D and vitamin D levels status in Puerto Ricans

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 4 SUPPL., 2013, Pages 38-47

  Suárez Martínez, Edu B ^a   Pérez, Cynthia M ^b   Cruz, Sofia K ^c   Khorsandi, Shayan ^c   Chardón, Camile ^d   Ferder, Leon ^c  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^c PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^d University of Puerto Rico at Ponce   (Puerto Rico)

Author keywords

Obesity; Puerto Ricans; Puerto Rico; Vitamin D

Indexed keywords

VITAMIN D;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD; ETHNOLOGY; FEMALE; HEALTH CARE PLANNING; HUMAN; MALE; MIDDLE AGED; PUERTO RICO; SEX DIFFERENCE; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; PUERTO RICO; SEX FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84887742728     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2014.0000     Document Type: Article

References (39)

1. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25- dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002 Mar 13;(3): 621-629.
2. Holick MF, Chen TC, Lu Z, et al. Vitamin D and skin physiology: a D- lightful story. J Bone Miner Res. 2007 Dec; 22 Suppl 2:V28-V33.
3. Silvagno F, De Vivo E, Attanasio A, et al. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One. 2010 Jan 13;5(1):e8670.
4. Hultin H, Edfeldt K, Sundbom M, et al. Left- shifted relation between calcium and parathyroid hormone in obesity. J Clin Endocrinol Metab. 2010 Aug; 95(8): 3973-3981. Epub 2010 Jun 2.
5. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010; 2010: 351385.
6. Zittermann A, Gummert JF, Börgermann J. The role of vitamin D in dyslipidemia and cardiovascular disease. Curr Pharm Des. 2011; 17(9): 933-942.
7. Wu- Wong JR. Are vitamin D receptor activators useful for the treatment of thrombosis? Curr Opin Investig Drugs. 2009 Sep; 10(9): 919-927.
8. Guillot X, Semerano L, Saidenberg-Kermanac'H N, et al. Vitamin D and inflamma-tion. Joint Bone Spine. 2010 Dec; 77(6): 552-557. Epub 2010 Nov 9.
9. Wu-Wong JR. Vitamin D therapy in cardiac hypertrophy and heart failure. Curr Pharm Des. 2011; 17(18): 1794-1807.
10. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007 Dec; 22 Suppl 2:V64-V68.
11. Yetley EA, Brulé D, Cheney MC, et al. Dietary reference intakes for vitamin D: jus-tif cation for a review of the 1997 values. Am J Clin Nutr. 2009 Mar; 89(3): 719-727. Epub 2009 Jan 28.
12. Holick MF, Binkley NC, Bischof - Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul; 96(7): 1911-1930. Erratum in J Clin Endocrinol Metab. 2011 Dec;96(12):3908.
13. Mithal A, Wahl DA, Bonjour JP, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009 Nov; 20(11): 1807-1820. Epub 2009 Jun 19. Erratum in: Osteoporos Int. 2009 Nov; 20(11): 1821.
14. Bischof - Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 Jul; 84(1): 18-28.
15. Need AG, Morris HA, Horowitz M, et al. Effects of skin thickness, age, body fat, and sunlight on serum 25- hydroxyvitamin D. Am J Clin Nutr. 1993 Dec; 58(6): 882-885.
16. van den Berg H. Bioavailability of vitamin D. Eur J Clin Nutr. 1997 Jan; 51 Suppl 1:S76-S79.
17. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec; 80(6 Suppl): 1678S-1688S.
18. Clemens TL, Adams JS, Nolan JM, et al. Measurement of circulating vitamin D in man. Clin Chim Acta. 1982 Jun 3; 121(3): 301-308.
19. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997 Aug; 30(2 Pt 1): 150-6.
20. Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987 Jun; 64(6): 1165-1168.
21. Holick M. Does sunscreen block the skin's ability to make vitamin D? If so, how can I get enough of this vitamin without raising my risk of skin cancer? Health News. 2002 Jul;8(7):12.
22. Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet B and blood pressure. Lancet. 1998 Aug 29; 352(9129): 709-710.
23. Tangpricha V, Turner A, Spina C, et al. Tanning is associated with optimal vitamin D status (serum 25- hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004 Dec; 80(6): 1645-1649.
24. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 Sep; 72(3): 690-693.
25. Vilarrasa N, Maravall J, Estepa A, et al. Low 25- hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest. 2007 Sep; 30(8): 653-658.
26. Blum M, Dallal GE, Dawson-Hughes B. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr. 2008 Apr; 27(2):274-279.
27. Institute of Medicine. Dietary reference intakes for vitamin D and calcium. Washington, DC: National Academies Press, 2011.
28. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta- analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10; 167(16): 1730-1737.
29. Jamal-Allial A, Tucker KL. Plasma vitamin D concentrations and dietary sources among Puerto Ricans living in the greater Boston area. FASEB J. 2010 Apr; 24(221.3).
30. Palacios C, Gil K, Pérez CM, et al. Determinants of vitamin D status among overweight and obese Puerto Rican adults. Ann Nutr Metab. 2012; 60(1): 35-43.
31. van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25- OH- vitamin D in human serum using liquid chromatography tandem- mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 1; 878(15-16): 1163-1168. Epub 2010 Mar 25.
32. Moon HW, Cho JH, Hur M, et al. Comparison of four current 25- hydroxyvitamin D assays. Clin Biochem. 2012 Mar; 45(4-5): 326-330. Epub 2012 Jan 8.
33. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 Dec 9; 52(24): 1949-1956.
34. Carter GD. Accuracy of 25- hydroxyvitamin D assays: confronting the issues. Curr Drug Targets. 2011 Jan; 12(1): 19-28.
35. Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011 Mar;(59): 1-8.
36. Batieha A, Khader Y, Jaddou H, et al. Vitamin D status in Jordan: dress style and gender discrepancies. Ann Nutr Metab. 2011; 58(1): 10-18. Epub 2011 Jan 19.
37. Khader Y, Batieha A, Ajlouni H, et al. Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab Syndr Relat Disord. 2008 Jun;6(2):113-120.
38. Pérez CM, Sánchez H, Ortiz AP. Prevalence of Overweight and Obesity and Their Cardiometabolic Comorbidities in Hispanic Adults Living in Puerto Rico. J Community Health. 2013 Jul 12.
39. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009 Feb; 19(2): 73-78. Epub 2008 Mar 10.